Development of a Next-Generation Immunoprevention Platform Against HIV-1

Awarded Award Notice Posted

Solicitation number
PHS-2024-1
Agency
National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Awarded
to Neovaxsyn Inc.
Set-aside
Total Small Business

Opportunity facts

Contract number
75N93024C00050 Federal contract award
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Place of performance
Ames, Iowa 50011, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services' National Institute of Allergy and Infectious Diseases awarded a $300,000 contract to NEOVAXSYN INC on August 1, 2024 for the Development of a Next-Generation Immunoprevention Platform Against HIV-1. This award falls under the Total Small Business set-aside category.

Notice text

Awarded contract 75N93024C00050 to NEOVAXSYN INC for 300000.00 on 2024-08-01.

Notice history

And 3 more award notices.

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity